People

Anuradha Banerjee, MD

Attending Physician
Pediatric Hematology/Oncology

Robert Goldsby, MD

Attending Physician
Pediatric Hematology/Oncology

Clay Gustafson, MD, PhD

Attending Physician
Pediatric Hematology/Oncology

Fabienne Hollinger

Nurse Practitioner
Pediatric Hematology/Oncology

Mignon Loh, MD

Attending Physician
Pediatric Hematology/Oncology

Sabine Mueller, MD, PhD

Attending Physician
Pediatric Hematology/Oncology

Amit Sabnis, MD

Attending Physician
Pediatric Hematology/Oncology

Elliot Stieglitz, MD

Attending Physician
Pediatric Hematology/Oncology

Juvenile myelomonocytic leukemia (JMML) is a blood cancer that affects young children and is often difficult to diagnose and treat. Currently available therapies cure only half of patients, with some children experiencing an aggressive disease course while a rare group get better with very little treatment. We have now shown that presence of secondary mutations via deep sequencing or droplet digital PCR predicts a poor outcome. We are currently working on developing a methylation based assay to predict both good and poor responders at diagnosis.

Kieuhoa Vo, MD

Attending Physician
Pediatric Hematology/Oncology